Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 418

The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.

Gut Microbiota and Complications of Type-2 Diabetes

Open access
Iatcu, Camelia Oana, Steen, Aimee, Covasa, Mihai·2021·Nutrients

Abstract

The gut microbiota has been linked to the emergence of obesity, metabolic syndrome and the onset of type 2 diabetes through decreased glucose tolerance and insulin resistance. Uncontrolled diabetes can lead to serious health consequences such as impaired kidney function, blindness, stroke, myocardial infarction and lower limb amputation. Despite a variety of treatments currently available, cases of diabetes and resulting complications are on the rise. One promising new approach to diabetes focuses on modulating the gut microbiota with probiotics, prebiotics, synbiotics and fecal microbial transplantation. Differences in gut microbiota composition have been observed in preclinical animal models as well as patients with type 2 diabetes and complications such as diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, cerebrovascular disease, coronary heart disease and peripheral artery disease compared to healthy controls. Severity of gut microbiota dysbiosis was associated with disease severity and restoration with probiotic administration in animal models and human patients has been associated with improvement of symptoms and disease progression. Characterizing the gut microbiota dysbiosis in different diseases and determining a causal relationship between the gut microbiota and disease can be beneficial in formulating therapeutic interventions for type 2 diabetes and associated complications. In this review, we present the most important findings regarding the role of the gut microbiota in type 2 diabetes and chronic complications as well as their underlying mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu14010166

Cites

172 of 172 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 172 references

Research works printed but not linked: 7

  1. Kowalewska, 2016, Higher diversity in fungal species discriminates children with type 1 diabetes mellitus from healthy control, Patient Prefer. Adherence, 10, 591
  2. Gupta, 2011, Targeted therapies in diabetic nephropathy: An update, J. Nephrol., 24, 686, 10.5301/jn.5000041 · doi:10.5301/jn.5000041
  3. Jeganathan, 2011, The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy, Curr. Pharm. Biotechnol., 12, 392, 10.2174/138920111794480615 · doi:10.2174/138920111794480615
  4. LI, 2018, Recombinant Probiotics Expressing Angiotensin-(1-7) Improves Glucose Metabolism and Diabetes-Induced Renal and Retinal Injury, Diabetes, 67, 33-LB, 10.2337/db18-33-LB · doi:10.2337/db18-33-lb
  5. George, 2020, Effects of Probiotic on the Development of Diabetic Retinopathy, Investig. Ophthalmol. Vis. Sci., 61, 4961
  6. Sawacha, 2010, A New Classification of Diabetic Gait Pattern Based on Cluster Analysis of Biomechanical Data, J. Diabetes Sci. Technol., 4, 1127, 10.1177/193229681000400511 · doi:10.1177/193229681000400511
  7. Bjerg, 2015, Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8(R) shows modest effect on triacylglycerol in young healthy adults, Benef. Microbes., 6, 29, 10.3920/BM2014.0058 · DOI

Cited by

See all 418

Metadata

Authors
Iatcu, C. O., Steen, A., & Covasa, M.
Venue
Nutrients
Publisher
MDPI AG
Published
2021-12-30
Volume
14
Issue
1
Pages
166
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4206445672
Cited by
418
References
172
FWCI
15.77
Type
journal article
Language
en
Open access
gold
Funders
European Regional Development Fund through Competitiveness Operational Program (120/16.09.2016.)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut Microbiota and Complications of Type-2 Diabetes. https://app.cochat.ai/papers/10.3390/nu14010166
The paper
Iatcu, C. O., Steen, A., & Covasa, M. (2021). Gut Microbiota and Complications of Type-2 Diabetes. Nutrients. https://doi.org/10.3390/nu14010166

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.